Agilon Health Lowers FY2026 Sales Guidance from $5.680B-$5.805B to $1.445B-$1.475B vs $5.719B Est

Agilon Health (NYSE: AGL ) lowers FY2026 sales outlook from $5.680 billion-$5.805 billion to $1.445 billion-$1.475 billion vs $5.719 billion estimate.